Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025
Nanobiotix (NASDAQ: NBTX), a late-clinical stage biotechnology company focused on nanoparticle-based cancer treatments, has announced its participation in two major investor conferences in early 2025.
The company will participate in fireside chats at the following events:
- Guggenheim SMID Cap Biotech Conference on February 6, 2025, at 1pm ET in New York, featuring CFO Bart van Rhijn
- Leerink Global Healthcare Conference on March 12, 2025, at 10:40pm ET in Miami, featuring CEO Laurent Levy and CFO Bart van Rhijn
Both fireside chats will be webcast live through the company's website's Investors section, with replays available after the events.
Nanobiotix (NASDAQ: NBTX), un'azienda biotecnologica in fase finale di sviluppo clinico, specializzata in trattamenti oncologici basati su nanoparticelle, ha annunciato la sua partecipazione a due importanti conferenze per investitori all'inizio del 2025.
L'azienda prenderà parte a discussioni informali nei seguenti eventi:
- Guggenheim SMID Cap Biotech Conference il 6 febbraio 2025, alle 13:00 ET a New York, con la partecipazione del CFO Bart van Rhijn
- Leerink Global Healthcare Conference il 12 marzo 2025, alle 22:40 ET a Miami, con la partecipazione del CEO Laurent Levy e del CFO Bart van Rhijn
Entrambe le discussioni informali saranno trasmesse in diretta attraverso la sezione dedicata agli investitori del sito web dell'azienda, con repliche disponibili dopo gli eventi.
Nanobiotix (NASDAQ: NBTX), una empresa biotecnológica en etapa clínica avanzada centrada en tratamientos contra el cáncer basados en nanopartículas, ha anunciado su participación en dos importantes conferencias para inversores a principios de 2025.
La empresa participará en charlas informales en los siguientes eventos:
- Guggenheim SMID Cap Biotech Conference el 6 de febrero de 2025, a la 1:00 PM ET en Nueva York, con la participación del CFO Bart van Rhijn
- Leerink Global Healthcare Conference el 12 de marzo de 2025, a las 10:40 PM ET en Miami, con la participación del CEO Laurent Levy y del CFO Bart van Rhijn
Ambas charlas se transmitirán en vivo a través de la sección de inversores del sitio web de la empresa, con repeticiones disponibles después de los eventos.
Nanobiotix (NASDAQ: NBTX), 나노입자 기반의 암 치료에 주력하는 임상 후기 단계의 생명공학 회사가 2025년 초에 두 개의 주요 투자자 회의에 참여한다고 발표했습니다.
회사는 다음 행사에서 편안한 대화에 참여할 예정입니다:
- 구겐타임 SMID 캡 생명공학 회의 2025년 2월 6일 오후 1시 ET, 뉴욕에서 CFO Bart van Rhijn이 참석합니다.
- 리린크 글로벌 헬스케어 회의 2025년 3월 12일 오후 10시 40분 ET, 마이애미에서 CEO Laurent Levy와 CFO Bart van Rhijn이 참석합니다.
각 대화는 회사 웹사이트의 투자자 섹션을 통해 실시간으로 방송되며, 이벤트 후 재생이 가능합니다.
Nanobiotix (NASDAQ: NBTX), une entreprise biopharmaceutique en phase clinique avancée spécialisée dans les traitements contre le cancer à base de nanoparticules, a annoncé sa participation à deux grandes conférences pour investisseurs début 2025.
L'entreprise participera à des discussions informelles lors des événements suivants :
- Conférence Guggenheim SMID Cap Biotech le 6 février 2025 à 13h00 ET à New York, avec la participation du CFO Bart van Rhijn
- Conférence mondiale de santé Leerink le 12 mars 2025 à 22h40 ET à Miami, avec la participation du CEO Laurent Levy et du CFO Bart van Rhijn
Les deux discussions seront diffusées en direct sur la section investisseurs du site Web de l'entreprise, avec des rediffusions disponibles après les événements.
Nanobiotix (NASDAQ: NBTX), ein biopharmazeutisches Unternehmen in der späten klinischen Phase, das sich auf nanopartikelbasierte Krebsbehandlungen spezialisiert hat, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen zu Beginn des Jahres 2025 angekündigt.
Das Unternehmen wird an informellen Gesprächen bei den folgenden Veranstaltungen teilnehmen:
- Guggenheim SMID Cap Biotech Conference am 6. Februar 2025 um 13:00 Uhr ET in New York, mit CFO Bart van Rhijn
- Leerink Global Healthcare Conference am 12. März 2025 um 22:40 Uhr ET in Miami, mit CEO Laurent Levy und CFO Bart van Rhijn
Beide Gespräche werden live über den Investorenbereich der Unternehmenswebsite übertragen, wobei Aufzeichnungen nach den Veranstaltungen verfügbar sind.
- None.
- None.
PARIS and CAMBRIDGE, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in fireside chats at following conferences:
Guggenheim SMID Cap Biotech Conference
Date: Thursday, February 6, 2025
Time: 1pm ET / 7pm CET
Location: New York, NY
Presenter: Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix
Webcast link: Click here
Leerink Global Healthcare Conference
Date: Wednesday, March 12, 2025
Time: 10:40pm ET / 4:40pm CET
Location: Miami, FL
Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix
Webcast link: Click here
The fireside chats will be webcast live from the events page of the Investors section of the Company’s website. Replay of the webcast will be available following the event.
About NANOBIOTIX
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.
Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations.
Nanobiotix is the owner of more than 25 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.
For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.
Contacts
| Nanobiotix | ||
| Communications Department Brandon Owens VP, Communications +1 (617) 852-4835 contact@nanobiotix.com | Investor Relations Department Craig West SVP, Investor Relations +1 (617) 583-0211 investors@nanobiotix.com | |
| Media Relations | ||
France – HARDY Caroline Hardy +33 06 70 33 49 50 carolinehardy@outlook.fr | Global – LifeSci Advisors Kevin Gardner +1 (617) 283-2856 kgardner@lifesciadvisors.com | |
Attachments
FAQ
When is Nanobiotix (NBTX) presenting at the Guggenheim SMID Cap Biotech Conference 2025?
Who will represent NBTX at the Leerink Global Healthcare Conference 2025?
How can investors access Nanobiotix (NBTX) conference presentations in February and March 2025?
What is the schedule for NBTX's Leerink Global Healthcare Conference presentation in March 2025?
